In addition to tissue-specific-promoter- (such as PSPs) driven oncolytic approach, tumor-specific promoters including survivin, carcinoembryonic antigen (CEA), and telomerase have also been used in regulated E1A expression in oncolytic adenoviral approach. Here, CEACAM5 is linked to neoplasm.